Last reviewed · How we verify

Docusate — Competitive Intelligence Brief

Docusate (DOCUSATE SODIUM) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: docusate sodium. Area: Hematology.

discontinued docusate sodium Hematology Small molecule Live · refreshed every 30 min

Target snapshot

Docusate (DOCUSATE SODIUM). Docusate sodium works by increasing the solubility of bile salts in the gut, allowing more water to be absorbed into the stool.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Docusate TARGET DOCUSATE SODIUM discontinued docusate sodium

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (docusate sodium class)

  1. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Docusate — Competitive Intelligence Brief. https://druglandscape.com/ci/docusate-sodium. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: